While most side effects are mild and temporary, rare but serious allergic reactions can occur
The CONFIDENCE is currently examining the effect of empagliflozin and finerenone combination therapy on kidney outcomes in CKD patients with diabetes [58]
But its well-studied and has proven long-term safety
Robert Kushner: Well, GLP-1 and its sister drug GIP were first identified actually in the 1980s
Besides its popularity for weight loss, berberine is also being studied for its effect on diabetes and heart disease risk factors
Preliminary results indicate that such drugs might not only be effective for obesity and diabetes but also for a number of other diseases including osteoarthritis, Parkinson's disease and a range of conditions caused by a buildup of fat in the liver, known as nonalcoholic steatohepatitis (NASH) (Brandt, Mller, DiMarchi)